Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. DIAGNOS Inc.
  6. News
  7. Summary
    ADK   CA2524423068

DIAGNOS INC.

(ADK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

DIAGNOS : 2021-09-24, DIAGNOS to be Featured on CEO Clips on the BNN Bloomberg Channel – Download PDF

09/25/2021 | 01:12pm EDT

2021.09.24

DIAGNOS to be Featured on CEO Clips on the BNN Bloomberg Channel

BROSSARD, Quebec, Canada, September 24, 2021 - (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or "the Company") (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces it will be featured on CEO Clips on the BNN Bloomberg Channel on September 25th and 26th, 2021.

BTV's CEO Clips, a series of short video profiles on innovative publicly traded companies across North America, will feature DIAGNOS on the BNN Bloomberg Channel beginning September 25th, Saturday & Sunday, throughout the day and evenings. View link: https://b-tv.com/diagnos-using-ai-to-analyze-the-retina/

Further online distribution through BTV's CEO Clips includes: Thomson Reuters Terminals, Yahoo Finance, Stockwatch, Bloomberg, Stockhouse.com and BTV's YouTube channel.

About the BNN Bloomberg Channel and BTV:

BNN Bloomberg is Canada's only Business News Network reporting on finance and the markets.

BTV-BusinessTelevision and CEO Clips produce and create the largest library of issuer videos and campaigns for broadcast on TV and financial sites.

Contact: info@b-tv.com

About DIAGNOS

DIAGNOS is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications such as CARA (Computer Assisted Retina Analysis). CARA's image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients. CARA has been cleared for commercialization by the following regulators: Health Canada, the FDA (USA), CE (Europe), COFEPRIS (Mexico) and Saudi FDA (Saudi Arabia).

Additional information is available at www.diagnos.comand www.sedar.com.

For further information, please contact:

Mr. André Larente, President

DIAGNOS Inc.

Tel: 450-678-8882 ext. 224

2

alarente@diagnos.caCorporate Communications:

Nancy Massicotte

IR Pro Communications Inc. Dir: +1 604-507-3377

TF: 1-866-503-3377

Email: nancy@irprocommunications.com

This press release contains forward-looking information. We cannot guarantee that the forward-looking information mentioned will prove to be accurate, as there may be a significant discrepancy between actual results or future events and those mentioned in this statement. DIAGNOS disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this press release is expressly covered by this caution.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

- 30 -

FR-08.09EN-V2.0

Disclaimer

Diagnos Inc. published this content on 24 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 September 2021 17:11:03 UTC.


© Publicnow 2021
All news about DIAGNOS INC.
09/25DIAGNOS : 2021-09-24, DIAGNOS to be Featured on CEO Clips on the BNN Bloomberg Channel &nd..
PU
09/24DIAGNOS INC. : Using Artificial Intelligence to Analyze the Retina, CEO Clip Video
NE
09/24DIAGNOS : to be Featured on CEO Clips on the BNN Bloomberg Channel
AQ
09/16DIAGNOS : Announces Multi-Year Contract with Juarez Health & Medical Tourism Cluster in Me..
MT
09/16DIAGNOS : 2021-09-16, DIAGNOS Announces a Multi-Year Contract with Juarez Health & Medical..
PU
09/16DIAGNOS : Announces a Multi-Year Contract with Juarez Health & Medical Tourism Cluster
AQ
09/14DIAGNOS : 2021-09-14, DIAGNOS Announces a 3-Year Contract with Cielo Vista Eye Clinic in M..
PU
09/14DIAGNOS : Announces a 3-Year Contract with Cielo Vista Eye Clinic in Mexico
AQ
09/14Diagnos Inc Announces 3-Year Contract with Cielo Vista Eye Clinic in Mexico
CI
09/10DIAGNOS : Announces Voting Results of Annual Meeting of Shareholders
AQ
More news
Financials
Sales 2022 0,80 M 0,65 M 0,65 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -10,2x
Yield 2022 -
Capitalization 35,3 M 28,5 M 28,5 M
Capi. / Sales 2022 44,1x
Capi. / Sales 2023 4,45x
Nbr of Employees 22
Free-Float 69,7%
Chart DIAGNOS INC.
Duration : Period :
DIAGNOS Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 0,51 CAD
Average target price 1,55 CAD
Spread / Average Target 204%
EPS Revisions
Managers and Directors
André M. Larente President, Chief Executive Officer & Director
Marc-André Massue Chief Financial Officer, Secretary & VP-Finance
Vincent Duhamel Chairman
Reid Maclellan Independent Director
Francis Bellido Independent Director
Sector and Competitors
1st jan.Capi. (M$)
DIAGNOS INC.-13.56%28
MICROSOFT CORPORATION36.77%2 283 977
SEA LIMITED78.10%195 739
ATLASSIAN CORPORATION PLC75.20%103 110
ZOOM VIDEO COMMUNICATIONS, INC.-21.05%79 131
DASSAULT SYSTÈMES SE38.73%70 312